Literature DB >> 16807670

From molecular mimicry to cross-reactivity or pathogen expansion? A hypothesis.

Alexander P Rozin1.   

Abstract

Very recently, several studies have convincingly demonstrated the role of infection in the development of the antiphospholipid syndrome. Cross antibody-mediated reactivity due to molecular mimicry between endothelial glycoproteins and microbial products was considered as an important pathogenic mechanism. However, another consequence of the molecular mimicry may be proposed. Similar tissues have less likelihood of being rejected and have a greater chance of being accepted by the host. According to this principle, pathogens with common-to-host antigens may attach readily and not be eliminated. A direct expansion of such pathogens may involve new territories. The targets of the approach 1, "from molecular mimicry to cross-reactivity," are T-B cells system inhibition-modulation. The targets of approach 2, "from molecular mimicry to pathogen expansion," are pathogens, enforcement of barriers, elimination techniques, and preventive strategy.

Entities:  

Mesh:

Year:  2006        PMID: 16807670     DOI: 10.1007/s10067-006-0352-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  21 in total

1.  Staphylococcus aureus expresses a cell surface protein that binds both IgG and beta2-glycoprotein I.

Authors:  Lihong Zhang; Karin Jacobsson; Katrin Ström; Martin Lindberg; Lars Frykberg
Journal:  Microbiology       Date:  1999-01       Impact factor: 2.777

2.  Clarithromycin in adult-onset Still's disease. Case report with a 1-year follow-up.

Authors:  G Saviola; L Abdi Ali; S Shams Eddin; C Davoli; M Taglietti
Journal:  Clin Exp Rheumatol       Date:  2004 May-Jun       Impact factor: 4.473

Review 3.  Infectious origin of the antiphospholipid syndrome.

Authors:  Y Shoenfeld; M Blank; R Cervera; J Font; E Raschi; P-L Meroni
Journal:  Ann Rheum Dis       Date:  2006-01       Impact factor: 19.103

4.  Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo.

Authors:  Azzudin E Gharavi; Silvia S Pierangeli; Ricardo G Espinola; Xiaowei Liu; Margaret Colden-Stanfield; E Nigel Harris
Journal:  Arthritis Rheum       Date:  2002-02

5.  Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis.

Authors:  M M Newkirk; R Goldbach-Mansky; B W Senior; J Klippel; H R Schumacher; H S El-Gabalawy
Journal:  Rheumatology (Oxford)       Date:  2005-08-09       Impact factor: 7.580

6.  Alopecia areata and relapsing polychondritis or mosaic autoimmunity? The first experience of co-trimoxazole treatment.

Authors:  A P Rozin; D Schapira; R Bergman
Journal:  Ann Rheum Dis       Date:  2003-08       Impact factor: 19.103

7.  Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain.

Authors:  C C Kuo; A M Gown; E P Benditt; J T Grayston
Journal:  Arterioscler Thromb       Date:  1993-10

8.  Doxycycline versus doxycycline and rifampin in undifferentiated spondyloarthropathy, with special reference to chlamydia-induced arthritis. A prospective, randomized 9-month comparison.

Authors:  John D Carter; Joanne Valeriano; Frank B Vasey
Journal:  J Rheumatol       Date:  2004-10       Impact factor: 4.666

9.  Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies.

Authors:  S D Khare; H S Luthra; C S David
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307

10.  The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats.

Authors:  J D Taurog; J A Richardson; J T Croft; W A Simmons; M Zhou; J L Fernández-Sueiro; E Balish; R E Hammer
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

View more
  3 in total

Review 1.  The SAPHO syndrome revisited with an emphasis on spinal manifestations.

Authors:  Antonio Leone; Victor N Cassar-Pullicino; Roberto Casale; Nicola Magarelli; Alessia Semprini; Cesare Colosimo
Journal:  Skeletal Radiol       Date:  2014-10-21       Impact factor: 2.199

Review 2.  Sialic Acid-Siglec Axis as Molecular Checkpoints Targeting of Immune System: Smart Players in Pathology and Conventional Therapy.

Authors:  Przemyslaw Wielgat; Karol Rogowski; Katarzyna Niemirowicz-Laskowska; Halina Car
Journal:  Int J Mol Sci       Date:  2020-06-19       Impact factor: 5.923

3.  SAPHO syndrome: is a range of pathogen-associated rheumatic diseases extended?

Authors:  Alexander P Rozin
Journal:  Arthritis Res Ther       Date:  2009-11-05       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.